Literature DB >> 15465466

Harnessing the potential of cancer genetics in healthcare.

Gabriella Pichert1.   

Abstract

The advancement of knowledge in genetics will have a profound effect on prediction, prevention, and treatment of cancer. It has the potential to offer more personalised healthcare that accords with an individual's genetic profile. However, the complex medical, ethical, legal, and psychosocial issues brought by our ability to test healthy individuals for cancer predisposition and the fast pace of advances in genetics pose great challenges to the medical community. Individuals and families are unlikely to benefit from an effective and ethical application of new genetic knowledge unless high quality cancer-genetics services are developed and integrated into mainstream healthcare, more research is undertaken into the prevention, causes, and treatment of cancer, and further efforts are made to improve public understanding and acceptance of cancer genetics.

Entities:  

Mesh:

Year:  2004        PMID: 15465466     DOI: 10.1016/S1470-2045(04)01598-0

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  4 in total

1.  SEOM recommendations on the structure and operation of hereditary cancer genetic counseling units (HCGCUs).

Authors:  Enrique Lastra-Aras; Luis Robles-Díaz; Carmen Guillén-Ponce; Emilio Alba; Juan-Jesús Cruz
Journal:  Clin Transl Oncol       Date:  2012-08-22       Impact factor: 3.405

2.  The Teesside cancer family history service: change management and innovation at cancer network level.

Authors:  Paul Brennan; Oonagh Claber; Tracey Shaw
Journal:  Fam Cancer       Date:  2007-05-17       Impact factor: 2.375

Review 3.  Estimating the referral rate for cancer genetic assessment from a systematic review of the evidence.

Authors:  C Featherstone; A Colley; K Tucker; J Kirk; M B Barton
Journal:  Br J Cancer       Date:  2007-01-29       Impact factor: 7.640

4.  Pharmacogenomics and Theranostics in Practice: A summary of the Euromedlab-ESPT (The European Society of Pharmacogenomics and Theranostics) satellite symposium, May 2013.

Authors:  Gérard Siest; Edith Schallmeiner
Journal:  EJIFCC       Date:  2013-02-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.